Miconazole
1-[2-(2,4-Dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]imidazole
Drag to rotate. Structure from PubChem CID 4189.
Background
Listing
- Schedules
- Schedule 1 to 4, conditions apply
- Source
- Consolidated Schedules 06 July 2026
Registered medicines
2 registered products listed
Counted through the register's ingredient index, which does not reach every record.
| Name | Brands | Dosages | Applicants | Registrations | Schedule |
|---|---|---|---|---|---|
| Miconazole | Gyno-daktarin, Gyno-brentan vc, Covarex, +8 more | 2 %, 200 mg 1, dak-o-gel, gel, +3 more | 7 applicants | 13 registrations | S1 |
| Hydrocortisone, miconazole | Elozart, Daktacort | Not stated | 2 applicants | 2 registrations | S1 to S4conditions apply |
1 more registered product name Miconazole in their active ingredient
| Name | Brands | Dosages | Applicants | Registrations | Schedule |
|---|---|---|---|---|---|
| Miconazole, polymyxin b, prednisolone | Otilan | Not stated | Cipla Medpro (Pty) Ltd | 31-Jul |
Regulatory status
Where S1 to S4 sits on the scale
Depends on which listing applies
At the least restrictive, Schedule 1: sold by a pharmacist, no doctor's prescription needed. At the most restrictive, Schedule 4: prescription-only medicine. The listings below say which applies to which form, strength or pack size.
Schedule S1 to S4, as the Consolidated Schedules list it.
Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.
Consolidated Schedules listings for Miconazole
S4: Miconazole
- except when intended for application to the skin; (S1) and
- except when intended for human vaginal use, specifically for the treatment of recurrent vaginal candidiasis; (S1) and
- except when intended for human use in preparations containing 2 per cent or less of miconazole, when intended for the topical treatment of fungal infections of the mouth (oral candidiasis). (S2)
Consolidated Schedules 06 July 2026, lines 7125 to 7130
S2: Miconazole
- when intended for human use in preparations containing 2 percent or less of miconazole, for the topical treatment of fungal infections of the mouth (oral candidiasis). (S1, S4)
Consolidated Schedules 06 July 2026, lines 2347 to 2348
S1: Miconazole
- when intended for human vaginal use specifically for the treatment of recurrent vaginal candidiasis; (S4) and
- when intended for application to the skin. (S4)
- except for topical treatment of fungal infections of the mouth. (S2)
Consolidated Schedules 06 July 2026, lines 838 to 851
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.